Researchers from Institute of Science Tokyo discovered that tongue cancer cells resist chemotherapy by activating autophagy and cholesterol synthesis pathways. Using a library of tongue cancer organoids, they identified mechanisms behind minimal residual disease, offering new treatment avenues. Their findings, published in Developmental Cell, highlight potential for personalized medicine in combating chemo-resistant tongue cancer.